Pages Report] Rising demand for Pharmaceuticals Industry will drive the Congestive Heart Failure (Chf) Treatment Devices segment growth over the next five years. Global Marke …
Read Full Story at source (may require registration)
Latest posts by CHF Editor (see all)
- EUR/CHF Price Analysis: Eyes 1.0000 as Credit Suisse’s debacle continues to weigh on Swiss Franc - March 21, 2023
- Partners Group reports continued management fee growth; performance fees in line with guidance; dividend up 12% to CHF 37.00 per share - March 21, 2023
- Credit Suisse and the power of money - March 21, 2023
